Perioperative Therapy for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors

Perioperative Therapy for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors

The emergence of immune checkpoint inhibitors (ICIs) has dramatically changed the treatment landscape for patients with metastatic non-small cell lung cancer (NSCLC). These achievements inspired investigators and pharmaceutical companies to conduct clinical trials in patients with early-stage NSCLC...

Full description

Bibliographic Details
Main Authors: Junichi Soh, Akira Hamada, Toshio Fujino, Tetsuya Mitsudomi
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
lung cancer
immune checkpoint inhibitor
perioperative therapy
neoadjuvant therapy
adjuvant therapy
Online Access:https://www.mdpi.com/2072-6694/13/16/4035

Internet

https://www.mdpi.com/2072-6694/13/16/4035

Similar Items